Skip to main content
. 2022 Aug 18;64(1):5558. doi: 10.4102/safp.v64i1.5558

TABLE 3.

Results of regression analysis.

Variables Whole sample HBA1c Non-well-controlled sample HBA1c Well-controlled sample HBA1c
Received HDM (= 1) −0.464**
(−0.831 to −0.0977)
−0.380*
(−0.732 to −0.0269)
−0.0646
(−0.272 to 0.143)
Follow-up (= 1) 0.266
(−0.0606 to 0.593)
0.330*
(0.0116 to 0.648)
0.122
(−0.0496 to 0.294)
Age 0.186**
(0.0755 to 0.296)
0.163**
(0.0552 to 0.271)
0.0345
(−0.0291 to 0.0981)
Female (= 1) −0.109
(−0.500 to 0.282)
−0.195
(−0.573 to 0.183)
0.308***
(0.0941 to 0.522)
High BP (= 1) 0.517*
(0.0525 to 0.981)
0.0136
(−0.461 to 0.488)
0.0642
(−0.149 to 0.277)
Weight −0.0157**
(−0.0247 to −0.00664)
−0.0208**
(−0.0295 to −0.0121)
0.0110**
(0.00587 to 0.0161)

Note: Confidence intervals are reported in parentheses.

HBA1c, haemoglobin A1c; HDM, home delivery of medication.

*

p < 0.05;

**

p < 0.01.